Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on sleep in brain health

LIVE: Thursday 2nd May 2024, 18:00-19:30 (CEST)

Quality sleep is essential for health. But what happens to our brains when sleep patterns are disturbed? Join our experts to explore the interplay between sleep disruption and neurological diseases, and the questions that you need to be asking your patients to help you prevent the harmful effects of sleep deprivation.
ADVANCED SEARCH
Log in
Top
International Journal for Equity in Health
Published in: International Journal for Equity in Health 1/2017

Open Access 01-12-2017 | Research

More than a virus: a qualitative study of the social implications of hepatitis B infection in China

Authors: J. Wallace, M. Pitts, C. Liu, V. Lin, B. Hajarizadeh, J. Richmond, S. Locarnini

Published in: International Journal for Equity in Health | Issue 1/2017

Login to get access

Abstract

Background

China has the largest absolute number of people living with hepatitis B with up to 300,000 people estimated to die each year from hepatitis B related diseases. Despite advances in immunisation, clinical management, and health policy, there is still a lack of accessible and affordable health care for people with hepatitis B. Through in-depth interviews, this study identifies the personal, social and economic impact of living with hepatitis B and considers the role of stigma and discrimination as barriers to effective clinical management of the disease.

Methods

Semi-structured qualitative interviews were held with 41 people living with hepatitis B in five Chinese cities. Participants were recruited through clinical and non-government organisations providing services to people with hepatitis B, with most (n = 32) being under the age of 35 years.

Results

People living with hepatitis B experience the disease as a transformative intergenerational chronic infection with multiple personal and social impacts. These include education and employment choices, economic opportunities, and the development of intimate relationships. While regulations reducing access to employment and education for people with hepatitis B have been repealed, stigma and discrimination continue to marginalise people with hepatitis B.

Conclusions

Effective public policy to reduce morbidity and mortality associated with hepatitis B needs to address the lived impact of hepatitis B on families, employment and educational choices, finances, and social marginalisation.
Literature
1.
2.
Lu FM, Li T, Liu S, Zhuang H. Epidemiology and prevention of hepatitis B virus infection in China. J Viral Hepat. 2010;17
3.
Liang X, Bi S, Yang W, Wang L, Cui G, Cui F, Zhang Y, Liu J, Gong X, Chen Y, et al. Epidemiological serosurvey of hepatitis B in China–declining HBV prevalence due to hepatitis B vaccination. Vaccine. 2009;27:6550–7.
4.
Zhou Y-H, Wu C, Zhuang H. Vaccination against hepatitis B: the Chinese experience. Chinese Medical Journal. 2009;1:98–102.
5.
Cui F, Wang X, Cao L, Liang X, et al.: Progress in Hepatitis B Prevention Through Universal Infant Vaccination - China, 1997-2006. In Book Progress in Hepatitis B Prevention Through Universal Infant Vaccination - China, 1997–2006 (Editor ed.^eds.). pp. 441–445. City: U.S. Center for Disease Control; 2007:441-445.
6.
7.
McDonald M, Hertz R, Lowenthal S. The burden of cancer in Asia. In: Book The burden of cancer in Asia (Editor ed.^eds.). City: Pfizer Medical Division; 2008.
8.
World Health Organization. Global Health Sector Strategy on Viral Hepatitis, 2016-2021. In: Book Global Health Sector Strategy on Viral Hepatitis, 2016–2021 (Editor ed.^eds.). City: World Health Organisation; 2016.
9.
Liu K, Wu Q, Liu J. Examining the association between social health insurance participation and patients’ out-of-pocket payments in China: the role of institutional arrangement. Social science & medicine (1982). 2014;113:95–103.CrossRef
10.
Lok ASF, McMahon BJ. AASLD practice guidelines; Chronic hepatitis B: Update 2009. Hepatology. 2009;50:1–36.
11.
Papatheodoridis GV, Lampertico P, Manolakopoulos S, Lok A. Incidence of hepatocellular carcinoma in chronic hepatitis B patients receiving nucleos(t)ide therapy: a systematic review. J Hepatol. 2010;53:348–56.
12.
Jia J. Hepatitis B in China: from guideline to practice. Virol Sin. 2008;23:152–5.CrossRef
13.
Chen J, Zhang S. Liver cancer epidemic in China: Past, present and future. Semin Cancer Biol. 2011;21:59–69.CrossRefPubMed
14.
Li Z, Wang P, Gao G, Xu C, Chen X. Age-period-cohort analysis of infectious disease mortality in urban-rural China, 1990–2010. Int J Equity Health. 2016;15:55.CrossRefPubMedPubMedCentral
15.
Sun J, Hou JL: Management of chronic hepatitis B: experience from China. J Viral Hepat. 2010;17:10–7.
16.
Zheng X, Wang J, Yang D. Antiviral therapy for chronic hepatitis B in China. Med Microbiol Immunol. 2015;204:115–20.CrossRefPubMed
17.
Lu F-M, Zhuang H. Management of hepatitis B in China. Chin Med J. 2009;1:3–4.
18.
Yu R, Fan R, Hou J. Chronic hepatitis B virus infection: epidemiology, prevention, and treatment in China. Front Med. 2014;8:135–44.CrossRefPubMed
19.
Fang Q, Hao Y, Li L, Zhang Z, Wang J, Chen M, Kang J, Yang D. Chronic HBV Carrier’s acceptance of regular surveilling program in China. J Huazhong Univ Sci Technol [Med Sci]. 2013;33:288–92.CrossRef
20.
Levy AR, Kowdley KV, Iloeje U, Tafesse E, Mukherjee J, Gish R, Bzowej N, Briggs AH. The Impact of Chronic Hepatitis B on Quality of Life: A Multinational Study of Utilities from Infected and Uninfected Persons. Value Health. 2008;11:527–38.CrossRefPubMed
21.
Lu J, Xu A, Wang J, Zhang L, Song L, Li R, Zhang S, Zhuang G, Lu M. Direct economic burden of hepatitis B virus related diseases: evidence from Shandong China. BMC Health Serv Res. 2013;13:37.CrossRefPubMedPubMedCentral
22.
Li X, Xu WF. China's efforts to shed its title of “Leader in liver disease”. Drug discoveries & therapeutics. 2007;1:84–5.
23.
Yang T, Wu M-C. Discrimination against hepatitis B carriers in China. The Lancet. 2011;378:1059.
24.
Beijing Yirenping Centre. Understanding and Challenging Employment Discrimination against People Living with HBV in China. In: Book Understanding and Challenging Employment Discrimination against People Living with HBV in China. (Editor ed.^eds.). City: Beijing Yirenping Centre; 2010.
25.
Anqi L. Health Ministry to cancel hepatitis B tests for employment & school enrollment. In Book Health Ministry to cancel hepatitis B tests for employment & school enrollment. CCTV.com; 2009.
26.
Hu T, Du Q, Ren F, Liang S, Lin D, Li J, Chen Y. Spatial Analysis of the Home Addresses of Hospital Patients with Hepatitis B Infection or Hepatoma in Shenzhen, China from 2010 to 2012. Int J Environ Res Public Health. 2014;11:3143–55.CrossRefPubMedPubMedCentral
27.
Na L, Na B. A Revolutionary Road: An Analysis of Persons Living With Hepatitis B in China. J Health Commun. 2012;18:71–91.CrossRefPubMed
28.
Unattributed. Three departments further clarify hepatitis B screening item as part of pre-admission to schools/pre-employment medical examination to be cancelled. In Book Three departments further clarify hepatitis B screening item as part of pre-admission to schools/pre-employment medical examination to be cancelled. Xinhua News Agency; 2010.
29.
Ministry of Health: Notice on the further standardisation of health check up items in schooling and employment and the guarantee of the schooling and employment rights of people with hepatitis B surface antigen. In Book Notice on the further standardisation of health check up items in schooling and employment and the guarantee of the schooling and employment rights of people with hepatitis B surface antigen. Ministry of Health; 2010.
30.
Braun V, Clarke V. Using thematic analysis in psychology. Qual Res Psychol. 2006;3:77–101.CrossRef
31.
Ryan GW, Bernard HR, Denzin N, Lincoln Y: Handbook of qualitative research. Handbook of qualitative research 2000.
32.
Ellard J, Wallace J. Stigma, discrimination and hepatitis B, a review of current research. In: Book Stigma, discrimination and hepatitis B, a review of current research (Editor ed.^eds.). City: Australian Research Centre in Sex, Health and Society, La Trobe University; 2013.
33.
Hong C, Wei Q, Cheng M, Wang X, Han Z. Illness-related stigma and its effect on interaction anxiousness and general self-efficacy in outpatients with chronic viral hepatitis. Chinese Journal of Behavioral Medical Science. 2011;(9)809-811.
34.
Pettypiece S. For Chinese, a push against hepatitis stigma. In Book For Chinese, a push against hepatitis stigma. International Herald Tribune; 2007.
35.
Cotler SJ, Cotler S, Xie H, Luc BJ, Layden TJ, Wong SS. Characterizing hepatitis B stigma in Chinese immigrants. J Viral Hepat. 2011:147–52.
36.
Carabez R, Swanner A, Yoo G, Ho M. Knowledge and fears among Asian Americans chronically infected with hepatitis B. J Cancer Educ. 2014;29:522–8.CrossRefPubMed
37.
Guirgis M, Nusair F, Bu YM, Yan K, Zekry AT. Barriers faced by migrants in accessing healthcare for viral hepatitis infection. Intern Med J. 2012;42:491–6.CrossRefPubMed
38.
Li D, Tang T, Patterson M, Ho M, Heathcote J, Shah H. The impact of hepatitis B knowledge and stigma on screening in Canadian Chinese persons. Can J Gastroenterol. 2012;26:597–602.
39.
Huang J, Guan ML, Balch J, Wu E, Rao H, Lin A, Wei L, Lok AS. Survey of hepatitis B knowledge and stigma among chronically infected patients and uninfected persons in Beijing, China. Liver Int. 2016;36:1595–603.CrossRefPubMed
40.
Enescu A, Mitrut P, Balasoiu M, Turculeanu A, Enescu A. Psychosocial Issues in Patients with Chronic Hepatitis B and C. Current Health Sciences Journal. 2014;40:93–6.PubMedPubMedCentral
41.
Valizadeh L, Zamanzadeh V, Negarandeh R, Zamani F, Hamidia A, Zabihi A. Psychological Reactions among Patients with Chronic Hepatitis B: a Qualitative Study. Journal of caring sciences. 2016;5:57–66.CrossRefPubMedPubMedCentral
42.
Feng B, Zhang J, Wei L. Inadequate awareness of hepatitis C among nonspecialist physicians in China. Advances in Medical Education and Practice. 2011;2:209–14.PubMedPubMedCentral
43.
Chao J, Chang E, So S. Hepatitis B and liver cancer knowledge and practices among healthcare and public health professionals in China: a cross-sectional study. BMC Public Health. 2010;10:98.CrossRefPubMedPubMedCentral
Metadata
Title
More than a virus: a qualitative study of the social implications of hepatitis B infection in China
Authors
J. Wallace
M. Pitts
C. Liu
V. Lin
B. Hajarizadeh
J. Richmond
S. Locarnini
Publication date
01-12-2017
Publisher
BioMed Central
Published in
International Journal for Equity in Health / Issue 1/2017
Electronic ISSN: 1475-9276
DOI
https://doi.org/10.1186/s12939-017-0637-4

Other articles of this Issue 1/2017

International Journal for Equity in Health 1/2017 Go to the issue

Research

Priorities and strategies for improving Roma women’s access to primary health care services in cases on intimate partner violence: a concept mapping study

Systematic review

Identifying inequitable healthcare in older people: systematic review of current research practice

Research

The effect of health literacy and self-management efficacy on the health-related quality of life of hypertensive patients in a western rural area of China: a cross-sectional study

Research

Inequalities in health care utilization for common childhood illnesses in Ethiopia: evidence from the 2011 Ethiopian Demographic and Health Survey

Research

Socioeconomic disadvantage, fetal environment and child development: linked Scottish administrative records based study

Research

The Impact of the Share 35 Policy on Racial and Ethnic Disparities in Access to Liver Transplantation for Patients with End Stage Liver Disease in the United States: An Analysis from UNOS Database